2BB score and signals
Neumora Therapeutics, Inc.’s current 2BB score is 19 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 12 | Very Low |
| Momentum | 50 | Stable |
| Quality | 80 | Very Strong |
2BBBullish & Bearish
Neumora Therapeutics, Inc. (NMRA) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 19 out of 100.
Neumora Therapeutics, Inc.’s current 2BB score is 19 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 12 | Very Low |
| Momentum | 50 | Stable |
| Quality | 80 | Very Strong |
| Headquarters | Watertown, Massachusetts, United States |
| Founded | 2019 |
| Employees | 92 |
| 52-week range | $0.77 – $3.65 |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2026-11-04 | — | -0.2012 | — | $0.00 |
| 2026-08-12 | — | -0.2448 | — | $0.00 |
| 2026-05-12 | — | -0.3162 | — | $0.00 |
| 2026-03-30 | — | -0.3321 | — | $0.00 |